Modeling of receptor mimics that inhibit superantigen pathogenesis

Journal of Molecular Recognition

Volumn 18, Issue 1, 2005, Pages 73-83

  Möllhoff, Margit ^a   Vander Zanden, Hannah B ^a   Shiflett, Patrick R ^a   Gupta, Goutam ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Contact interface; DR linker TcRV chimera; Molecular modeling; Protein protein interaction; Superantigen chimera complex; Superantigens

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL TOXIN; ENTEROTOXIN; ENTEROTOXIN E, STAPHYLOCOCCAL; ENTEROTOXIN F, STAPHYLOCOCCAL; HLA ANTIGEN CLASS 2; HYBRID PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; MOLECULAR MIMICRY; PATHOGENICITY; PROTEIN TERTIARY STRUCTURE; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION;

ANTIGENS, BACTERIAL; BACTERIAL TOXINS; ENTEROTOXINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MODELS, MOLECULAR; MOLECULAR MIMICRY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT FUSION PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; SUPERANTIGENS;

EID: 11244265812     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.684     Document Type: Article

References (38)

1. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl. Acids Res. 25: 3389-3402.
2. Arcus VL, Proft T, Sigrell JA, Baker HM, Fraser JD, Baker EN. 2000. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes. J. Mol. Biol. 299(1): 157-168.
3. Balaban N, Rasooly A. 2000. Staphylococcal enterotoxins. Int. J. Food Microbiol. 61: 1-10.
4. Camacho CJ, Weng Z, Vajda S, DeLisi C. 1999. Free energy landscapes of encounter complexes in protein-protein association. Biophys. J. 76: 1166-1178.
5. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. 1989. Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells. Proc. Natl Acad. Sci. USA 86: 8941-8945.
6. Fields BA, Malchiodi EL, Li H, Ysern X, Stauffacher CV, Schlievert PM, Karjalainen K, Mariuzza RA. 1996. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature 384: 188-192.
7. Fraser JD. 1989. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 339: 221-223.
8. Fraser J, Arcus V, Kong P, Baker E, Proft T. 2000. Superantigens - powerful modifiers of the immune system. Mol. Med. Today 6: 125-132.
9. Guex N, Peitsch MC. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723. (All figures were made with the program Swissprot www.expasy.org/spdbv/)
10. Gunsteren van WF, Billeter SR, Eising AA, Hünenberger PH, Krüger P, Mark AE, Scott WRP, Tironi IG. 1996. Biomolecular Simulation: The GROMOS96 Manual and User Guide. Vdf Hochschulverlag AG an der ETH Zürich: Zürich.
11. Hennecke J, Wiley DC. 2002. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 195: 571-581.
12. Hennecke J, Carfi A, Wiley DC. 2000. Structure of a covalently stabilized complex of a human alpha/beta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 19: 5611-5624.
13. Hong-Geller E, Möllhoff M, Shiflett PR, Gupta G. 2004. Design of chimeric receptor mimics with different TcRVβ isoforms: type-specific inhibition of superantigen pathogenesis. J. Biol. Chem. JBC, 279: 5676-5684.
14. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Strominger JL, Wiley DC. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368: 711-718.
15. Jayasinghe S, Hristova K, White SH. 2001. Energetics, stability, and prediction of transmembrane helices. J. Mol. Biol. 312: 927-934.
16. Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston A, Carrel S, Posnett DN, Choi Y, Marrack P. 1989. V beta-specific stimulation of human T cells by staphylococcal toxins. Science 244: 811-813.
17. Kappler J, White J, Kozono H, Clements J, Marrack P. 1994. Binding of a soluble alpha beta T-cell receptor to super-antigen/major histocompatibility complex ligands. Proc. Natl Acad. Sci. USA 91: 8462-8466.
18. Kieke MC, Sundberg E, Shusta EV, Mariuzza RA, Wittrup KD, Kranz DM. 2001. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J. Mol. Biol. 307: 1305-1315.
19. Kierzek A, Zielenkiewicz P. 1997. Energy minimization of globular proteins with solvent effects included. Comparison of empirical solvation energy terms and explicit water treatment. Acta Biochim. Pol. 44: 549-556.
20. Kim J, Urban RG, Strominger JL, Wiley DC. 1994. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266: 1870-1874.
21. Koradi R, Billeter M, Thrich K. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 51-55; www.mol.biol.ethz.ch/wuthrich/software/molmol/
22. Kotb M. 1998. Superantigens of Gram-positive bacteria: structure-function analyses and their implications for biological activity. Curr. Opin. Microbiol. 1: 56-65.
23. Lavoie PM, Thibodeau J, Erard F, Sekaly R-P. 1999. Understanding the mechanism of action of bacterial superantigens from a decade of research. Immunol. Rev. 168: 257-269.
24. Lehnert NM, Allen DL, Allen BL, Catasti P, Shiflett PR, Chen M, Lehnert BE, Gupta G. 2001. Structure-based design of a bispecific receptor mimic that inhibits T cell responses to a superantigen. Biochemistry 40: 4222-4228.
25. Llewelyn M, Cohen J. 2002. Superantigens: microbial agents that corrupt immunity. Lancet Infect. Dis. 2: 156-162.
26. Marrack P, Winslow GM, Choi Y, Scherer M, Pullen A, White J, Kappler JW. 1993. The bacterial and mouse mammary tumor virus superantigens; two different, families of proteins with the same functions. Immunol. Rev. 131: 79-92.
27. Müller-Alouf H, Carnoy C, Simonet M, Alouf JE. 2001. Super-antigen bacterial toxins: state of the art. Toxicon 39: 1691-1701.
28. Olson MA. 2001. Calculations of free-energy contributions to protein-RNA complex stabilization. Biophys. J. 81: 1841-1853.
29. Papageorgiou AC, Acharya KR. 2000. Microbial super-antigens: from structure to function. Trends Microbiol. 8: 369-375.
30. Papageorgiou AC, Brehm RD, Leonidas DD, Tranter HS, Acharya KR. 1996. The refined crystal structure of toxic shock syndrome toxin-1 at 2.07 angstrom resolution. J. Mol. Biol. 260: 553-569.
31. Papageorgiou AC, Tranter HS, Acharya KR. 1998. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 Å resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J. Mol. Biol. 277: 61-79.
32. Pearlman DA, Case DA, Caldwell JW, Ross WH, Cheatham TS III, Ferguson DM, Seibel GL, Chandra Singh U, Weiner PK, Kollman PA. 1995. AMBER 4.1. University of California: San Francisco, CA.
33. Sundberg E, Li Y, Mariuzza R. 2002. So many ways of getting in the way: diversity in the molecular architecture of super-antigen-dependent T-cell signaling complexes. Curr. Opin. Immunol. 14: 36-44.
34. Ulrich RG, Bavari S, Olson MA. 1995. Bacterial superantigens in human disease: structure, function and diversity. Trends Microbiol. 3: 463-468.
35. Ulrich RG, Olson MA, Bavari S. 1998. Development of engineered vaccines effective against structurally related bacterial superantigens. Vaccine 16: 1857-1864.
36. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P. 1989. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56: 27-35.
37. White SH, Wimley WC. 1999. Membrane protein folding and stability: physical principles. A. Rev. Biophys. Biomol. Struct. 28: 319-365.
38. Zhang C, Vasmatzis G, Cornette JL, DeLisi C. 1997. Determination of atomic desolvation energies from the structures of crystallized proteins. J. Mol. Biol. 267: 707-726.